Related Experiment Video

Updated: Dec 9, 2025

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

3.1K

Pediatric type 1 diabetes research in the 21st century: a scientometric review

Brij M Gupta1, Devi Dayal2

  • 1Ex-Professor, CSIR-National Institute of Science, Technology and Development Studies, India.

Pediatric Endocrinology, Diabetes, and Metabolism
|September 9, 2020
PubMed

Insights

This study assessed global research on childhood type 1 diabetes (T1D). The USA leads in productivity, while Finland shows the highest impact, highlighting research gaps in developing nations.

Area of Science:

  • Pediatric endocrinology and diabetes research.
  • Bibliometrics and scientometrics.

Background:

  • Scientometric studies are crucial for identifying research gaps and informing future scientific endeavors.
  • Despite extensive research over two decades, a scientometric assessment of childhood onset type 1 diabetes (T1D) is lacking.

Purpose of the Study:

  • To conduct a comprehensive scientometric assessment of the global research output concerning pediatric type 1 diabetes (T1D).

Main Methods:

  • Analysis of publications on pediatric T1D from the Scopus database (2000-2019).
  • Identification of leading countries, organizations, and authors based on productivity and impact.
  • Examination of research trends, publication media, and characteristics of highly cited papers.

Main Results:

  • Pediatric T1D research demonstrated significant growth, with 7.84% annual and 79.99% 10-year cumulative increases.
  • The USA (29.76%) and UK (10.56%) were the most productive countries, while Finland (RCI 2.30) and UK (RCI 1.82) showed the highest relative citation impact.
  • Research output is concentrated in 10 countries (82.67%), with limited contribution from developing nations, particularly in Southeast Asia.

Conclusions:

  • The USA is the most productive country, and Finland is the most impactful in global pediatric T1D research.
  • Significant disparities exist in research contributions, with a notable lack of engagement from developing countries despite a substantial disease burden.
Abstract

Keywords:
bibliometricsglobal publicationsscientometricstype 1 diabeteschildren

More Related Videos

High Resolution 3D Imaging of the Human Pancreas Neuro-insular Network09:54

High Resolution 3D Imaging of the Human Pancreas Neuro-insular Network

Published on: January 29, 2018

11.4K
Author Spotlight: Advancing Type 1 Diabetes Research Using Innovative Pancreatic Slice Platforms08:16

Author Spotlight: Advancing Type 1 Diabetes Research Using Innovative Pancreatic Slice Platforms

Published on: March 15, 2024

1.9K

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.6K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.1K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.8K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
108
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
763
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
145